96 related articles for article (PubMed ID: 9456669)
1. Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis.
Diz Dios P; Iglesias I; Valcarcel JP; Ocampo A; Vazquez E; Castro M
Oral Dis; 1997 May; 3 Suppl 1():S113-5. PubMed ID: 9456669
[TBL] [Abstract][Full Text] [Related]
2. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
4. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
6. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
8. Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient.
Takasuka T; Baily GG; Birch M; Anderson MJ; Law D; Denning DW
J Infect; 1998 Jan; 36(1):57-62. PubMed ID: 9515670
[TBL] [Abstract][Full Text] [Related]
9. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Marr KA; White TC; van Burik JA; Bowden RA
Clin Infect Dis; 1997 Oct; 25(4):908-10. PubMed ID: 9356806
[TBL] [Abstract][Full Text] [Related]
10. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
11. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Milan EP; Burattini MN; Kallás EG; Fischmann O; Costa PR; Colombo AL
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):211-6. PubMed ID: 9884838
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Müller FM; Staudigel A; Salvenmoser S; Tredup A; Miltenberger R; Herrmann JV
Antimicrob Agents Chemother; 2007 Aug; 51(8):3014-6. PubMed ID: 17548494
[TBL] [Abstract][Full Text] [Related]
13. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
Marr KA; Lyons CN; Ha K; Rustad TR; White TC
Antimicrob Agents Chemother; 2001 Jan; 45(1):52-9. PubMed ID: 11120944
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
Löffler J; Einsele H; Hebart H; Schumacher U; Hrastnik C; Daum G
FEMS Microbiol Lett; 2000 Apr; 185(1):59-63. PubMed ID: 10731607
[TBL] [Abstract][Full Text] [Related]
15. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.
Rodríguez-Tudela JL; Martínez-Suárez JV; Dronda F; Laguna F; Chaves F; Valencia E
J Antimicrob Chemother; 1995 Jun; 35(6):793-804. PubMed ID: 7559191
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
17. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
White A; Goetz MB
Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
[TBL] [Abstract][Full Text] [Related]
18. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.
Ha KC; White TC
Antimicrob Agents Chemother; 1999 Apr; 43(4):763-8. PubMed ID: 10103178
[TBL] [Abstract][Full Text] [Related]
19. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
20. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.
Ruhnke M; Schmidt-Westhausen A; Morschhäuser J
J Antimicrob Chemother; 2000 Aug; 46(2):291-5. PubMed ID: 10933656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
